Cargando…
Andrographolide Inhibits Epstein–Barr Virus Lytic Reactivation in EBV-Positive Cancer Cell Lines through the Modulation of Epigenetic-Related Proteins
Reactivation of Epstein–Barr virus (EBV) is associated with EBV-associated malignancies and is considered to be a benefit target for treatment. Andrographolide is claimed to have antiviral and anti-tumor activities. Therefore, this study aimed to investigate the effect of andrographolide on the inhi...
Autores principales: | Malat, Praphatson, Ekalaksananan, Tipaya, Heawchaiyaphum, Chukkris, Suebsasana, Supawadee, Roytrakul, Sittiruk, Yingchutrakul, Yodying, Pientong, Chamsai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316603/ https://www.ncbi.nlm.nih.gov/pubmed/35889536 http://dx.doi.org/10.3390/molecules27144666 |
Ejemplares similares
-
Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer
por: Malat, Praphatson, et al.
Publicado: (2021) -
The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2023) -
Association of Human Papillomavirus and Epstein-Barr Virus Infection with Tonsil Cancer in Northeastern Thailand
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2022) -
Epstein-Barr Virus Infection Alone or Jointly with Human Papillomavirus Associates with Down-Regulation of miR-145 in Oral Squamous-Cell Carcinoma
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2021) -
General Features and Novel Gene Signatures That Identify Epstein-Barr Virus-Associated Epithelial Cancers
por: Heawchaiyaphum, Chukkris, et al.
Publicado: (2021)